Marker Therapeutics Q3 EPS $(0.34) Up From $(0.80) YoY, Sales $257.61K Down From $3.95M YoY
Portfolio Pulse from Benzinga Newsdesk
Marker Therapeutics reported Q3 losses of $(0.34) per share, a 57.5% increase from $(0.80) per share YoY. Sales were $257.61K, a 93.48% decrease from $3.95M YoY.
November 10, 2023 | 12:03 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Marker Therapeutics reported a YoY increase in losses per share but a significant decrease in sales.
The company's losses per share have increased year over year, which is a negative sign. However, the significant decrease in sales is a major concern and could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100